跳至主要内容
临床试验/NCT07575217
NCT07575217Enrolling By Invitation不适用

A Mail-based HPV Sampling Program to Increase Cervical Cancer Screening in New Jersey

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年7月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
200
试验地点
1

研究概览

简要总结

The purpose of this study is to help people who have missed their regular cervical cancer screening. The investigators are evaluating whether mailing an HPV self-sampling kit to participant home makes it easier and more convenient for people to get screened for cervical cancer. This study will also help to understand if people find this process acceptable and whether it is an effective way to improve screening rates.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women, transgender men, and nonbinary individuals aged 30 to 75 who have a cervix.
  • No history of hysterectomy or cervical cancer.
  • No documented cervical cancer screening within guideline-recommended intervals: specifically, no Pap test in the past 3.5 years, no Pap/HPV co-test in the past 5.5 years, and no standalone HPV test results in the past 5.5 years. (A 6-month grace period is included to allow time for response to usual care outreach.)
  • At least two visits to University Hospital ambulatory care over the past five years, ensuring opportunity for follow-up and continuity of care.

排除标准

  • History of cervical dysplasia within the past 3.5 years, reflecting those likely under active surveillance or treatment protocols.
  • Currently pregnant, due to differing screening recommendations and clinical considerations.
  • Prior or current diagnosis of cervical cancer or ongoing treatment for cervical neoplasia.
  • Physical, cognitive, or functional limitations that would preclude use of the mailed self-sampling kit without assistance. Examples include severe arthritis or significant impairment affecting self-collection capability.
  • Lack of a telephone number or reliable mailing address on file.
  • Inability to communicate in English or Spanish, given study materials and staffing capabilities. Use of additional language services is not available.
  • Current enrollment in other cervical cancer screening or intervention studies that may interfere with participation or outcomes.
  • Inability to provide informed consent or comprehend study procedures based on cognitive capacity, as assessed by the Research Coordinator during initial contact.

研究组 & 干预措施

Standard Pap Smear

Active Comparator

Participants will have the option to choose a standard pap smear for cervical cancer screening

干预措施: Standard Pap Smear (Diagnostic Test)

HPV Self-Sampling Test

Experimental

Participants are able to opt-in for an at-home self-sampling HPV test for cervical cancer screening

干预措施: BD Onclarity HPV test (Diagnostic Test)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana Isabel Tergas, MD, MPH

Director, Division of Gynecologic Oncology

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验